Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Ylva Morud is MQ’s new Head of Design- and Buying

Ylva Morud is the new Head of Design- and Buying at MQ. Ylva comes from a position as Head of Buying at Weekday where she is responsible for both internal and external brands at buying and design. Ylva will take up the position as Head of Design- and Buying at MQ from 1th November 2019. Ylva has long experience from retail and has had several positions within HM, including Head of Buying at &other stories and several manager positions in the buying organization at HM. Ylva also established the global buying organisation for the production organisation. "I look forward to becoming part

Raisio's Financial Reporting and Annual General Meeting in 2020

Raisio plc, Stock Exchange Release, 22 August 2019 RAISIO’S FINANCIAL REPORTING AND ANNUAL GENERAL MEETING IN 2020 Raisio plc will publish its Financial Statements Bulletin for 2019 on Wednesday 12 February 2020. The Financial Statements, the Report of the Board of Directors and the Corporate Responsibility Report for 2019 will be published in week 10/2020. The publication dates of Raisio’s financial reports for 2020 are as follows:- Interim Report for January-March on Wednesday, 6 May 2020,- Half-Year Financial Report for January-June on Wednesday, 5 August 2020,- Interim

RhoVac AB has been granted 2.5 million euro from Horizon 2020

RhoVac AB ("RhoVac") announces today, 22th August  2019, that the EU Commission grants 2.5 million euro to RhoVac, from the research and innovation program Horizon 2020.The grant from the EU framework program Horizon 2020 runs over 36 months and supports the company's further development of the RV001 project for prostate cancer treatment, as well as continued business development with the aim of reaching an agreement with a future partner. In its assessment, the Commission finds the company's development plans well thought-out and realistic. The Commission emphasizes that the RV001 project

NetEnt boosts offering with enhanced Butterfly Staxx 2™

The sequel to the highly popular original game includes new pick-and-click features, multiple play areas and guarantees maximum magical enjoyment for all player typesThe colourful and enchanting world of butterflies is now even more magical with Butterfly Staxx 2TM– the latest release from NetEnt has been enhanced with a pick and click bonus game offering even more ways to win. In this 5-reel, 4-row, 40-fixed line video slot, players can unlock up to three play areas in a single bet, where the reels in each play area spin independently and simultaneously. This innovation is

Polygiene Grows in China with Commercial and Marketing Appointments

With the appointments of Jenny Zhu as Commercial Director and Amy Dai as Marketing and Supply Chain Manager in Shanghai, Polygiene is adding key competence to further strengthen the sales and technical organization in China.”I am very happy to announce the appointment of Jenny Zhu and Amy Dai who will complement our China team with competence that will be essential in reaching the ambitious goals we have for this market. As we are in the process of starting a subsidiary in Shanghai, I see the set-up of this professional organization as an important and logic step ”, states Ulrika Björk, CEO

Lipum presents at Biostock Live

On this autumn’s first BioStock Live Investor Event you have the chance to listen to presentations and talk with representatives from five life science companies.On August 27, Lipums CEO Einar Pontén will present our recent progress towards a novel treatment of chronic inflammatory diseases. The presentation will be broadcasted live on the web from 10am. Participating companies: · Dicot  · Lipidor  · Lipum  · Oncology Venture  · Redwood Pharma  Program:

AlzeCure publishes its interim report for January - June 2019

August 22, 2019 AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the January - June 2019 is now available on the company’s website: https://www.alzecurepharma.se/sv/section/investerare/finansiella-rapporter/Financial information for April - June 2019 · Net sales during the period amounted to SEK 0 thousand (0) · Earnings after financial items amounted to SEK –10,255 thousand (–7,724) · Earnings per share before and after dilution amounted to SEK –0.27 (–0.41) Financial information for January - June 2019 · Net sales during the

Invitation to Caverion’s Capital Markets Day 2019

Caverion Corporation Investor News 22 August 2019 at 10.00 a.m. EESTInvitation to Caverion’s Capital Markets Day 2019 Caverion has the pleasure to invite analysts, institutional investors and media to its Capital Markets Day in Helsinki, Finland. The event will take place on Tuesday, 5 November 2019 at 11.00 a.m.−5 p.m. local time (EET) at Kasarmikatu 21 (Kasarmikatu 21 B, 00130 Helsinki).  The event focuses on Caverion’s growth plans and business prospects. Through management presentations, the attendees will hear about Caverion’s roadmap to reach the strategic and financial targets

Johan Magnusson appointed new President and CEO of Kährs Group

The board of Kährs Holding AB (publ), Kährs Group, today announces the appointment of Johan Magnusson as new group CEO. Johan Magnusson brings years of experience in a range of pan-European and global companies and was most recently Managing Director at Owens Corning & Senior Vice President of Paroc Technical Insulation. Johan Magnusson replaces Christer Persson and will start his appointment at the latest on September 1, 2019.“We are very happy to welcome Johan Magnusson to Kährs and are excited about him taking the company towards continued growth in the future and further development.

Risk Intelligence A/S launches new office in Singapore and hires regional Director for Asia

Risk Intelligence A/S (“Risk Intelligence”) announces today that the Company launches a new office in Singapore and has hired a Regional Director for Asia.An important part of the Risk Intelligence growth plan and strategy is to be closer to our clients and markets in Asia and Risk Intelligence has now established a new office in Singapore. Risk Intelligence has had clients in the region since 2007 and the new office will be responsible for expanding the business in Asia whilst enhancing customer relations for the growing client portfolio in the region. To head this development Risk

Hedin Belgien Bil AB acquires Rudi Vertommen NV.

Gothenburg, August 22nd 2019 I.A. Hedin Bil AB has through its subsidiary, Hedin Belgien Bil AB, entered an agreement to acquire Rudi Vertommen NV. The deal includes a full-service dealership for PC and LCV Mercedes-Benz. The dealership operates under the brand Vertommen and is situated in Boortmeerbeek.- In 2018, Hedin Bil successfully took over the operations of 12 Mercedes-Benz dealerships in and around Ghent and Antwerp. The acquisition of Rudi Vertommen NV. complements our existing business in a strategic way and I look forward to further expand our offer in the Belgian market”,

CONTEMPLATING THE ISSUANCE OF SENIOR UNSECURED BONDS

Bonheur ASA is contemplating the issuance of NOK 700 million in a 5 year NOK denominated floating rate senior unsecured bond. DNB Markets and SpareBank1 Markets have been retained as joint lead managers of the potential bond issue. For further information, please contact: Øyvind B. Kristiansen, Fred. Olsen & Co., +47 90 01 05 29 or oyvindk@fredolsen.com or Haakon Magne Ore, Fred. Olsen & Co., +47 92 02 75 10 or hmore@fredolsen.com

ChromoGenics receives an order from Hungary to a value of SEK 450.000

ChromoGenics has received a High-Performance Glass order for a privately owned exclusive villa property. The property is under production and is located overlooking the Donau River outside Budapest in Hungary."We are very pleased that the property owner has noticed ChromoGenics and also prioritized the performance of the glass. There will now be no needs to install external sun protection to cope with the comfort during all four seasons," says CEO Jerker Lundgren.

Senzime’s Interim report January – June 2019

Press release: Uppsala, August 22, 2019. Senzime AB’s (publ) Interim report for January – June 2019 is now available on the company’s webbsite www.senzime.com. Financial information second quarter 2019 ·  Net sales amounts to KSEK 1 218 (381) ·  Income after financial items amounts to KSEK -9,153 (-5,543) ·  Earnings per share before dilution amounts to SEK -0.17 (-0.12) We are now halfway into the year and work on the launch of TetraGraph continues at an intensive pace. A breakthrough order of 50 pcs. TetraGraph systems from South Korea in May were quickly followed

The usefulness of Bioservo Technologies’ patented and award-winning SEM technology demonstrated in scientific study

A recently published article in the scientific journal PLOS ONE demonstrates that Bioservo Technologies’ wearable soft-robotic glove may counter hand function decline associated with ageing.In the article “Home rehabilitation supported by a wearable soft-robotic device for improving hand function in older adults: A pilot randomized controlled trial”* research results are reported demonstrating that support of the soft-robotic glove either as an assistive device or as a training tool may be a promising way to counter hand function decline associated with ageing. The randomized controlled

Borr Drilling Limited – Notice of Annual General Meeting 2019

A copy of the Notice of Annual General Meeting and Form of Proxy, and associated information including the Company’s Annual Report can be found on the Company’s website at http://www.borrdrilling.com and attached to this press release. The notice and associated information will also be distributed to shareholders by normal distribution methods. Hamilton, Bermuda22 August 2019 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Borr Drilling AGM Notice 2019 with byelaws 

Borr Drilling Limited – Paal Kibsgaard recommended as new Chairman of the Board

The Board of Borr Drilling has based on the unanimous decision from the nomination committee, decided to recommend Paal Kibsgaard as new Chairman of the Board of Borr Drilling. The election will take place at the annual general meeting to be held on September 27, 2019. Mr. Kibsgaard has through his 27 years of experience, a deep knowledge of the oil and gas industry. He has held a variety of global senior management positions at Schlumberger Limited, including Chairman and CEO, COO, President of the Reservoir Characterization Group, VP of Engineering, Manufacturing and Sustaining, and VP

Interim report quarter 2 -  Continued Efemia market expansion with Germany in sight

SECOND QUARTER (April - June 2019) · The company’s sales amounted to 101 (0) KSEK. · Work capitalised by the company for its own use amounted to 0 (187) KSEK. · Operating costs amounted to 3,243 (2,043) KSEK. · Result after tax amounted to -3,143 (-1,857) KSEK. · Result per share amounted to -0.30 (-0.19) SEK. CEO Karin Bryder summarizes the quarter  During the second quarter of 2019, we continued to focus on establishing and marketing Invent Medic’s first product Efemia Bladder Support in Sweden, the Nordic region and Europe. The marketing activities are targeting

Interim Report January – June 2019

Significant events during the second quarter 2019 · SRK Consulting is retained to perform a scoping study of the potential in the Väsman field. · Exploration permit for Ludvikafältet # 1 is granted by the Swedish Mining Inspectorate. · Golder Associates informed that the feasibility study will be delayed by approx. one month. · A short-term credit facility amounting to SEK 10 m was granted by the two largest owners. · Timo Lindborg was elected member of the board at the AGM. Second quarter, 1 April – 30 June 2019 · Income amounted to SEK 0 million (0) · Earnings

SEMCON IN NEW DIGITAL TWINS PARTNERSHIP

Creating virtual copies of physical products offers great opportunities for future product development. Semcon is now entering a new partnership with EDRMedeso, which develops and sells software for design, development and simulation.“We are very pleased that EDRMedeso is becoming one of our partners in digital twin development. Together with our extensive expertise in product development, we can offer digital solutions at the very cutting edge of technology with a clear user focus,” says Markus Granlund, CEO of Semcon. When a virtual copy is created and can be connected with a physical

Cantargia publishes half year report

Cantargia AB’s (”Cantargia”) half year report for the period January until June 2019 is now available on the company’s web page www.cantargia.com/en/investors/financial-reports.Significant events in the second quarter  · In May 2019, Cantargia AB and Patheon Biologics B.V. (a part of ThermoFischer Scientific) signed an agreement on future production of the CAN04 antibody.  · In May 2019, Cantargia announced new preclinical results showing positive effects when the CAN04 antibody is combined with various platinum-based chemotherapies. · New phase I clinical data on Cantargia´s

Ericsson announces changes to the Executive Team

· Fadi Pharaon is appointed Senior Vice President, and Head of Market Area Middle East & Africa, effective September 1, 2019 · Member of Ericsson's Executive Team, reporting to CEOEffective September 1, 2019, Fadi Pharaon is appointed Senior Vice President and Head of Market Area Middle East & Africa at Ericsson (NASDAQ: ERIC), and member of Ericsson’s Executive Team, reporting to the CEO. Fadi Pharaon currently holds the position as Vice President, Networks & Managed Services within Ericsson’s Market Area Europe & Latin America. Börje Ekholm, President and CEO of Ericsson, says: "

ExpreS 2 ion Biotech Holding AB: Publication of interim report for January – June 2019

ExpreS2ion Biotech Holding AB (“ExpreS2ion”) hereby publishes its interim report for the period January – June 2019. The report is available as an attached document to this press release and on the Company’s website (www.expres2ionbio.com). Below is a summary of the report.CEO Steen Klysner comments “The sales and marketing activities initiated in 2018 are beginning to show significant results. Compared to H1 2018 ExpreS[2]ion is able to present a revenue growth of 34 %. During H1 2019 we also witnessed a large and continuous growth in our potential revenue pipeline. We expect to

There are no items matching the current filter
There are no more items matching the current filter
Back to top